Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Romanian Journal of Internal Medicine = Revue Roumaine De Medecine Interne|December 17, 2014
Small intestinal bacterial overgrowth is associated to symptoms in irritable bowel syndrome. Evidence from a multicentre study in RomaniaIoana G Moraru, A G Moraru, M Andrei, et al.Chirurgia (Bucharest, Romania : 1990)|October 25, 2006
[D2 lymph node dissection in gastric cancer surgery: long term results--analysis of an experience with 227 patients]C Vasilescu, V Herlea, S Tidor, et al.Maedica|February 28, 2012
Nuclear Division Index may Predict Neoplastic Colorectal LesionsMirela E Ionescu, Mihai Ciocirlan, Gabriel Becheanu, et al.Chirurgia (Bucharest, Romania : 1990)|January 9, 2013
Noninvasive clinical model for the diagnosis of nonalcoholic steatohepatitis in overweight and morbidly obese patients undergoing bariatric surgeryI Pirvulescu, L Gheorghe, I Csiki, et al.Liver International : Official Journal of the International Association for the Study of the Liver|May 15, 2015
Prevalence and impact on survival of hepatopulmonary syndrome and cirrhotic cardiomyopathy in a cohort of cirrhotic patientsAndrei M Voiosu, Ioana C Daha, Theodor A Voiosu, et al.Revista Medico-Chirurgicala a Societatii De Medici Si Naturalisti Din Iasi|August 1, 2014
The efficacy of the Peginterferon treatment in chronic hepatitis HDV and compensate liver cirrhosisLetitia Tugui, M Dumitru, Speranta Iacob, et al.World Journal of Gastroenterology|February 17, 2015
Biological therapy in inflammatory bowel diseases: access in Central and Eastern EuropeFanni Rencz, Márta Péntek, Martin Bortlik, et al.Investigational New Drugs|March 17, 2007
A randomised phase II study of OSI-7904L versus 5-fluorouracil (FU)/leucovorin (LV) as first-line treatment in patients with advanced biliary cancersT Ciuleanu, M Diculescu, N M Hoepffner, et al.Journal of Viral Hepatitis|February 4, 2018
Risk of hepatitis B virus reactivation in hepatitis B virus + hepatitis C virus-co-infected patients with compensated liver cirrhosis treated with ombitasvir, paritaprevir/r + dasabuvir + ribavirinC M Preda, C P Popescu, C Baicus, et al.Current Health Sciences Journal|December 21, 2018
Adalimumab and Infliximab in Crohn's disease - real life data from a national retrospective cohort studyC Preda, L Fulger, L Gheorghe, et al.Pageof 4